Skip to main content

Delirium in the Intensive Care Unit

0
Pipeline Programs
1
Companies
2
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Ceribell
CeribellCA - Sunnyvale
2 programs
Ceribell Delirium Monitoring SystemN/A1 trial
Ceribell EEG SystemN/A1 trial
Active Trials
NCT07449416Recruiting100Est. Dec 2026
NCT07485244Recruiting100Est. Sep 2027

Trial Timeline

Clinical trial activity over time

2026
2027
CeribellCeribell EEG System
CeribellCeribell Delirium Monitoring System

Clinical Trials (2)

Total enrollment: 200 patients across 2 trials

NCT07485244CeribellCeribell EEG System

EEG Abnormalities in Adult ICU Patients With High Risk of Delirium

Start: Apr 2026Est. completion: Sep 2027100 patients
N/ARecruiting
NCT07449416CeribellCeribell Delirium Monitoring System

Ceribell Delirium Monitor Outcomes Pilot Study

Start: Mar 2026Est. completion: Dec 2026100 patients
N/ARecruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 actively recruiting trials targeting 200 patients
1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.